The patient working group is a brand new initiative within the NE&Y RTC.
Following the February 2026 update to NICE QS138 Statement 2 on tranexamic acid (TXA), the QS138 Quality Insights quality improvement tool has been updated to reflect the broadened eligibility criteria.
National Transfusion Practitioners Network
Lead: Stuart Lord
National Transfusion Practitioners Network